Bio-Rad Labs (BIO) Investor Day Highlights Successful Turnaround, Next Comes Multiple Expansion - Jefferies
Tweet Send to a Friend
Jefferies analyst Brandon Couillard reiterated a Buy rating and $780.00 price target on Bio-Rad Labs (NYSE: BIO) after attending the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
